Research Article
Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer
Figure 7
The TIED score and sensitivity scores of high- and low-risk groups. (a) Differences analysis of PD-1, PD-L1, and CTLA-4 in the high- and low-risk groups, basing on the TIED score of targeted immune checkpoints. (b) Sensitivity scores to whole immune checkpoints in high-low risk groups. (c) Sensitivity of the high- and low-risk groups predicted by the SubMap algorithm; R for immunotherapy responders and noR for immunotherapy nonresponders. , corrected by Bonferroni, was considered statistically significant.
(a) |
(b) |
(c) |